Filing Details

Accession Number:
0001104659-20-078441
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-30 08:20:25
Reporting Period:
2020-06-29
Accepted Time:
2020-06-30 08:20:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1579428 Axsome Therapeutics Inc. AXSM Pharmaceutical Preparations (2834) 454241907
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1658379 Mark Coleman C/O Axsome Therapeutics, Inc.
200 Broadway, 3Rd Floor
New York NY 10038
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-29 650 $78.50 403,698 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,100 Indirect See Footnote
Footnotes
  1. 250,000 shares were previously transferred to the reporting person's former spouse for no consideration pursuant to a property settlement agreement entered into in connection with a divorce proceeding. The reporting person no longer reports as beneficially owned any securities owned by his former spouse.
  2. Represents additional shares held indirectly by the reporting person prior to June 29, 2020. See Footnote 3.
  3. Such shares were purchased by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.